Skip to main content
. 2022 Jul 12;12(4):495–506. doi: 10.21037/hbsn-21-453

Table 3. The performance of our model compared with CRS.

Our model Fong CRS Relative improvement
Overall survival
   1-year survival 0.651 (95% CI: 0.537–0.765) 0.571 (95% CI: 0.514–0.628) 13.9%
   5-year survival 0.574 (95% CI: 0.517–0.630) 13.5%
Recurrence-free survival 0.651 (95% CI: 0.597–0.705)

CRS, Clinical Risk Score; CI, confidence interval.